---
layout: post
title: "Blood Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments"
date: 2026-02-05 18:35:46 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-04270
original_published: 2023-03-02 00:00:00 +0000
significance: 8.00
---

# Blood Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** March 02, 2023 00:00 UTC
**Document Number:** 2023-04270

## Summary

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Blood Products Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues related to blood and products derived from blood. At least one portion of the meeting will be closed to the public. FDA is establishing a docket for public comment on this document.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/02/2023-04270/blood-products-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-for)
- API: https://www.federalregister.gov/api/v1/documents/2023-04270

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
